Replies to post #240667 on Biotech Values

[RNsidersbuying]

From the NEJM link:

...The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group...

...A total of 32 deaths had occurred by completion of the blinded phase, with 16 deaths each (0.1%) in the placebo and mRNA-1273 groups; no deaths were considered to be related to injections of placebo or vaccine, and 4 were attributed to Covid-19 (3 in the placebo group and 1 in the mRNA-1273 group) (Tables S19 and S26)...

Did 103 "severe disease" cases in the placebo group fully recover or am I in confusion over specific dates??

https://www.nejm.org/doi/10.1056/NEJMoa2113017